Abstract

Chronic wounds remain one of the most challenging problems facing healthcare professionals with their ever-increasing impact on various domains of healthcare and well-being . Numerous management modalities have been proposed to reduce the clinical burden and healthcare costs associated with chronic wounds . Given the pivotal role debridement plays in wound care, it became a focus of interest for new therapeutic strategies in recent years . Herein, we report our experience with the SyllableTM Ultrasonic Surgical Debridement System manufactured by Mavera Medical Devices Inc. in a patient presenting with recalcitrant grade 3 stage D diabetic foot ulcers by the UT (University of Texas) system.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.